Zycan Single Dose Injection

Country: Australia

Language: English

Source: APVMA (Australian Pesticides and Veterinary Medicines Authority)

Active ingredient:

GLYCOSAMINOGLYCAN POLYSULFATE

Available from:

RANDLAB AUSTRALIA PTY LTD

Pharmaceutical form:

PARENTERAL LIQUID/SOLUTION/SUSPENSION

Composition:

GLYCOSAMINOGLYCAN POLYSULFATE EMULSIFIERS & SURFACTANTS Active 100.0 mg/ml

Units in package:

12 x 5 mL; 5mL; 7 X 5 mL

Class:

VM - Veterinary Medicine

Therapeutic area:

MUSCULOSKELETAL SYSTEM

Product summary:

Poison schedule: 4; Withholding period: DO NOT USE less than 28 days before slau ghter for human consumption; Host/pest details: HORSE: [DEGENERATIVE ASEPTIC JOINT DISEASE]

Authorization status:

Registered

Authorization date:

2023-07-01

Patient Information leaflet

Product Name:
APVMA Approval No:
Zycan Single Dose Injection
87359/122628
Label Name:
Zycan Single Dose Injection
Signal Headings:
PRESCRIPTION ANIMAL REMEDY
KEEP OUT OF REACH OF CHILDREN
FOR ANIMAL TREATMENT ONLY
Constituent
Statements:
100 mg/mL Polysulphated Glycosaminoglycan
Claims:
An aid in the treatment of traumatic or degenerative aseptic joint
disease in horses.
Net Contents:
5mL
7 x 5 mL
12 x 5 mL
Directions for Use:
Restraints:
Contraindications:
Precautions:
Use with caution in animals with pathologically increased bleeding
risks or in cases
of advanced renal or hepatic disease. Zycan will increase the action
of anticoagulant
preparation due to its structural relationship to heparin.
Side Effects:
Dosage and
Administration:
Administer the contents of 1 vial (5 mL) by intra-muscular injection
every four days for a
total of seven injections.
In the presence of active joint inflammation, prior or concomitant
therapy with a suitable
anti-inflammatory agent should be used. The anti-inflammatory
treatment should be
discontinued as soon as possible since steroidal and non-steroidal
anti-inflammatory
agents contribute to the degeneration of cartilage. RLP APPROVED
When Zycan is mixed with local anaesthetics in concentrations over 1%
or with
corticosteroid crystalline suspensions, sedimentation may occur.
General Directions:
Zycan Single Dose Injection exerts its activity by a biphasic
mechanism involving
stimulation of cartilage and synovial metabolism as well as inhibition
of degrading enzymes
which are responsible for joint deterioration.
Zycan Single Dose Injection substantially improves the ability of
cartilage to withstand
stress and helps to restore normal joint function.
Withholding Periods:
DO NOT USE less than 28 days before slaughter for human consumption.
Trade Advice:
Safety Directions:
First Aid Instructions:
If poisoning occurs, contact a doctor or Poisons Information Centre.
Phone 13 11 26.
First Aid Warnings:
Additional User
Safety:
Environmental
Statements:
Disposal:
Dispose of empty containe